Precision BioSciences Inc.

8.61-0.3300-3.69%Vol 107.74K1Y Perf 35.77%
Apr 16th, 2021 09:53 DELAYED
BID8.55 ASK8.62
Open9.11 Previous Close8.94
Pre-Market- After-Market-
 - -%  - -
Target Price
18.40 
Analyst Rating
Strong Buy 1.00
Potential %
105.82 
Finscreener Ranking
★★★★ —    54.00
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★+     44.40
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★+ —    57.85
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap491.99M 
Earnings Rating
Buy
Price Range Ratio 52W %
34.24 
Earnings Date
21st May 2021

Today's Price Range

8.559.11

52W Range

4.4516.60

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
3.95%
1 Month
-20.25%
3 Months
-20.88%
6 Months
31.09%
1 Year
35.77%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
DTIL8.61-0.3300-3.69
AAPL133.66-0.8400-0.62
GOOG2 286.33-10.3300-0.45
MSFT258.35-1.1500-0.44
XOM56.74-0.2400-0.42
WFC42.830.59001.40
JNJ161.000.61000.38
FB305.09-2.7300-0.89
GE13.51-0.0400-0.30
JPM153.130.96000.63
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.50-0.4412.00
Q03 2020-0.68-0.5026.47
Q02 2020-0.60-0.63-5.00
Q01 2020-0.53-0.521.89
Q04 2019-0.51-0.3629.41
Q03 2019-0.56-0.4126.79
Q02 2019-0.51-0.3923.53
----
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.490.00-
6/2021 QR-0.51-6.25Negative
12/2021 FY-2.00-6.38Negative
12/2022 FY-1.7812.32Positive
Next Report Date21st May 2021
Estimated EPS Next Report-0.49
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume107.74K
Shares Outstanding57.14M
Trades Count666
Dollar Volume11.66M
Avg. Volume1.00M
Avg. Weekly Volume578.76K
Avg. Monthly Volume804.56K
Avg. Quarterly Volume1.01M

Precision BioSciences Inc. (NASDAQ: DTIL) stock closed at 8.94 per share at the end of the most recent trading day (a 2.64% change compared to the prior day closing price) with a volume of 561.52K shares and market capitalization of 491.99M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 223 people. Precision BioSciences Inc. CEO is Matthew Kane.

The one-year performance of Precision BioSciences Inc. stock is 35.77%, while year-to-date (YTD) performance is 7.19%. DTIL stock has a five-year performance of %. Its 52-week range is between 4.45 and 16.6, which gives DTIL stock a 52-week price range ratio of 34.24%

Precision BioSciences Inc. currently has a PE ratio of -4.30, a price-to-book (PB) ratio of 11.43, a price-to-sale (PS) ratio of 27.56, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -53.66%, a ROC of -89.60% and a ROE of -111.79%. The company’s profit margin is -%, its EBITDA margin is -443.10%, and its revenue ttm is $17.29 Million , which makes it $0.30 revenue per share.

Of the last four earnings reports from Precision BioSciences Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.49 for the next earnings report. Precision BioSciences Inc.’s next earnings report date is 21st May 2021.

The consensus rating of Wall Street analysts for Precision BioSciences Inc. is Strong Buy (1), with a target price of $18.4, which is +105.82% compared to the current price. The earnings rating for Precision BioSciences Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Precision BioSciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Precision BioSciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.98, ATR14 : 1.03, CCI20 : -75.64, Chaikin Money Flow : -0.12, MACD : -0.83, Money Flow Index : 49.55, ROC : -5.40, RSI : 50.52, STOCH (14,3) : 26.42, STOCH RSI : 1.00, UO : 36.62, Williams %R : -73.58), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Precision BioSciences Inc. in the last 12-months were: Abid Ansari (Option Excercise at a value of $22 115), David Thomson (Sold 10 000 shares of value $164 900 ), Derek Jantz (Option Excercise at a value of $6 884), Derek Jantz (Sold 68 677 shares of value $799 468 ), Matthew Kane (Option Excercise at a value of $9 466), Matthew Kane (Sold 107 323 shares of value $1 277 259 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
6 (100.00 %)
7 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.

CEO: Matthew Kane

Telephone: +1 919 314-5512

Address: 302 East Pettigrew Street, Durham 27701, NC, US

Number of employees: 223

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits